Large-scale conformational dynamics of the HIV-1 integrase core domain and its catalytic loop mutants.
HIV-1 integrase is one of the three essential enzymes required for viral replication and has great potential as a novel target for anti-HIV drugs. Although tremendous efforts have been devoted to understanding this protein, the conformation of the catalytic core domain around the active site, particularly the catalytic loop overhanging the active site, is still not well characterized by experimental methods due to its high degree of flexibility. Recent studies have suggested that this conformational dynamics is directly correlated with enzymatic activity, but the details of this dynamics is not known. In this study, we conducted a series of extended-time molecular dynamics simulations and locally enhanced sampling simulations of the wild-type and three loop hinge mutants to investigate the conformational dynamics of the core domain. A combined total of >480 ns of simulation data was collected which allowed us to study the conformational changes that were not possible to observe in the previously reported short-time molecular dynamics simulations. Among the main findings are a major conformational change (>20 A) in the catalytic loop, which revealed a gatinglike dynamics, and a transient intraloop structure, which provided a rationale for the mutational effects of several residues on the loop including Q(148), P(145), and Y(143). Further, clustering analyses have identified seven major conformational states of the wild-type catalytic loop. Their implications for catalytic function and ligand interaction are discussed. The findings reported here provide a detailed view of the active site conformational dynamics and should be useful for structure-based inhibitor design for integrase.
Lee
Matthew C
MC
Department of Chemistry and Biochemistry, University of Delaware, Newark, Delaware 19716, USA.
Deng
Jinxia
J
Briggs
James M
JM
Duan
Yong
Y
D001665:Binding Sites; D002384:Catalysis; D020134:Catalytic Domain; D016000:Cluster Analysis; D003198:Computer Simulation; D019427:HIV Integrase / Q000737:chemistry* / Q000235:genetics*; D015497:HIV-1 / Q000201:enzymology*; D008024:Ligands; D008958:Models, Molecular; D008962:Models, Theoretical; D009154:Mutation; D017354:Point Mutation; D011485:Protein Binding; D011487:Protein Conformation; D017434:Protein Structure, Tertiary; D013997:Time Factors; D014779:Virus Replication
D008024:Ligands; D019427:HIV Integrase
J Comput Chem. 2003 Dec;24(16):1999-2012
14531054
J Virol. 1989 Jun;63(6):2629-37
2724412
J Mol Biol. 1998 Jun 26;279(5):1193-210
9642095
J Virol. 2000 May;74(10):4795-806
10775618
J Virol. 1994 Aug;68(8):4768-75
8035478
Virology. 1992 Jun;188(2):459-68
1585629
J Med Chem. 2004 Apr 8;47(8):1879-81
15055986
Cell. 1987 May 8;49(3):347-56
3032450
Science. 1995 Mar 10;267(5203):1443-4
7878462
Curr Drug Targets Infect Disord. 2002 Sep;2(3):217-34
12462126
Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11244-9
11016953
Curr Pharm Des. 2003;9(22):1789-802
12871197
Nucleic Acids Res. 2004 Jan 1;32(Database issue):D185-8
14681390
Proteins. 1993 Dec;17(4):412-25
8108382
Curr Drug Targets Infect Disord. 2002 Mar;2(1):17-32
12462150
Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9598-602
1409671
J Mol Biol. 1997 Mar 7;266(4):814-30
9102471
Nucleic Acids Res. 1991 Dec 25;19(24):6691-8
1662361
J Virol. 1998 May;72(5):3916-24
9557677
Nucleic Acids Res. 1993 Jul 25;21(15):3373-7
8346016
Mol Cell Biol. 1992 May;12(5):2331-8
1314954
Curr Drug Targets Infect Disord. 2001 Aug;1(2):133-49
12455410
Proc Natl Acad Sci U S A. 1986 Oct;83(20):7648-52
2429313
J Mol Biol. 2001 Feb 23;306(3):591-605
11178916
FEBS Lett. 1996 Dec 2;398(2-3):175-8
8977101
Mol Cells. 2000 Oct 31;10(5):525-32
11101143
Biochemistry. 1999 Jul 13;38(28):8892-8
10413462
Expert Opin Ther Targets. 2001 Aug;5(4):443-464
12540259
J Virol. 1997 May;71(5):3507-14
9094622
J Biol Chem. 1993 Jan 25;268(3):2113-9
8420982
Electrophoresis. 1997 Dec;18(15):2714-23
9504803
Biophys J. 1996 Oct;71(4):1707-13
8889148
Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8233-8
10890912
Cell. 1995 Feb 10;80(3):379-88
7859280
Science. 1994 Dec 23;266(5193):1981-6
7801124
Antiviral Res. 1997 Dec;36(3):139-56
9477115
J Virol. 1998 Jun;72(6):5046-55
9573274
J Virol. 1992 Nov;66(11):6361-9
1404595
Biophys J. 1999 Jun;76(6):2999-3011
10354426
EMBO J. 1991 Jan;10(1):25-33
1989886
EMBO J. 1998 Oct 1;17(19):5832-43
9755183